ifosfamide has been researched along with Status Epilepticus in 4 studies
Status Epilepticus: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report 2 cases of nonconvulsive status epilepticus (NCSE) following infusion of ifosfamide." | 7.73 | Nonconvulsive status epilepticus due to ifosfamide. ( Akoglu, H; Aksoy, S; Cakar, M; Erman, M; Kilickap, S; Onal, IK; Tekuzman, G; Tufan, A, 2006) |
| "To describe a patient with ifosfamide-induced nonconvulsive status epilepticus." | 7.69 | Ifosfamide-induced nonconvulsive status epilepticus. ( Badesha, PS; Bhardwaj, A, 1995) |
| "We report the first case of nonconvulsive status epilepticus as a complication of chemotherapy with the nitrogen mustard derivative ifosfamide." | 7.68 | Ifosfamide-induced nonconvulsive status epilepticus. ( Bernard, J; Talwar, D; Wengs, WJ, 1993) |
| "To report 2 cases of nonconvulsive status epilepticus (NCSE) following infusion of ifosfamide." | 3.73 | Nonconvulsive status epilepticus due to ifosfamide. ( Akoglu, H; Aksoy, S; Cakar, M; Erman, M; Kilickap, S; Onal, IK; Tekuzman, G; Tufan, A, 2006) |
| " During the initial therapy, an ifosfamide-induced encephalopathy occurred as status epilepticus." | 3.72 | Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide? ( Bellos, F; Egerer, G; Harter, C; Ho, AD; Kasper, B; Krasniqi, F; Meissner, J, 2004) |
| "To describe a patient with ifosfamide-induced nonconvulsive status epilepticus." | 3.69 | Ifosfamide-induced nonconvulsive status epilepticus. ( Badesha, PS; Bhardwaj, A, 1995) |
| "We report the first case of nonconvulsive status epilepticus as a complication of chemotherapy with the nitrogen mustard derivative ifosfamide." | 3.68 | Ifosfamide-induced nonconvulsive status epilepticus. ( Bernard, J; Talwar, D; Wengs, WJ, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasper, B | 1 |
| Harter, C | 1 |
| Meissner, J | 1 |
| Bellos, F | 1 |
| Krasniqi, F | 1 |
| Ho, AD | 1 |
| Egerer, G | 1 |
| Kilickap, S | 1 |
| Cakar, M | 1 |
| Onal, IK | 1 |
| Tufan, A | 1 |
| Akoglu, H | 1 |
| Aksoy, S | 1 |
| Erman, M | 1 |
| Tekuzman, G | 1 |
| Wengs, WJ | 1 |
| Talwar, D | 1 |
| Bernard, J | 1 |
| Bhardwaj, A | 1 |
| Badesha, PS | 1 |
4 other studies available for ifosfamide and Status Epilepticus
| Article | Year |
|---|---|
Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoprevention; Female; Huma | 2004 |
Nonconvulsive status epilepticus due to ifosfamide.
Topics: Anticonvulsants; Antineoplastic Agents, Alkylating; Diazepam; Female; Humans; Ifosfamide; Levetirace | 2006 |
Ifosfamide-induced nonconvulsive status epilepticus.
Topics: Brain; Electroencephalography; Female; Humans; Ifosfamide; Middle Aged; Status Epilepticus | 1993 |
Ifosfamide-induced nonconvulsive status epilepticus.
Topics: Aged; Antineoplastic Agents, Alkylating; Carcinosarcoma; Female; Genital Neoplasms, Female; Humans; | 1995 |